by Anna Elliott
Volume 9, Issue 20, September 27, 2022
By Anna Elliott, Managing Director/Partner & Chris Conn, Business Development
In September, VERTESS Managing Directors, joined by members of the business development team, attended three national conferences: Cape Cod Symposium on Addictive Disorders, The National Association for Specialty Pharmacy Annual Meeting, and The Home Care Association of America Annual Leadership Conference. Dominating the tradeshow floors were exhibitors in the healthcare technology space. We estimated that these companies accounted for 40-60% of the exhibitors — a common thread intersecting the three different verticals represented at the meetings.
Such a substantial presence by companies in the IT space comes as no surprise. As EY recently noted, the technology sector drove global M+A activity in the first half of 2022. While the total value of the activity was down from record 2021 levels, technology still accounted for nearly a third of global M+A activity. Technology-focused deals are at double the level seen from 2015-19.
Our experience at the September meetings served to further validate what we've been witnessing throughout the year: Healthcare IT is an area of tremendous activity, and one that's showing no signs of slowing down. Here are eight additional observations about the growth and investment interest in the sector.
This lag has opened the door to new companies and solutions, and investors have been eager to get their money in early in the hopes that these businesses and their products will see rapid adoption. From appointment logistics to virtual care to the development of at-home testing kits, many niche companies have experienced significant upticks in funding largely attributable to the pandemic and its effects on care delivery and patient perception.
If you'd like to discuss your company's position in this current market and whether now would be a good time to pursue a sale or recapitalization, contact us. We'd welcome the opportunity to learn more about your business and discuss how we can work together to set yourself up for a successful 2023.
Thinking about selling your company? Unsure when you should start thinking about selling? Have general questions about selling? We're here to help. Email Anna Elliott Managing Director/Partner, at aelliott@vertess.com, or call +1.724.900.1377 or Chris Conn, Business Development at cconn@vertess.com or call +1.612.358.0707.
Anna Elliott is a Merger and Acquisition / Business Development professional with over 15 years of experience working in high-growth, healthcare technologies with specific experience in Deep Tech, SAAS, Artificial Intelligence, Machine Learning, Ambient Solutions, and healthcare companies.
As a specialist in healthcare for her entire career, a key area of expertise for Anna is to appeal to healthcare technology firms and industries that are growing or merging via Mergers + Acquisitions. She is skilled in microtargeting related to needs and opportunities throughout the entire process of business supply and demand. Her successes in this area have led to over $150 million in value to the organizations involved. In short, she is an expert in using technology to identify not only tasks that are at risk of failure but also opportunities that offer rapid, significant gains overall.
Anna furthered her career in M+A when she became a co-founder of a boutique Merger and Acquisition advisory firm in Pittsburgh, M&A Finders, where she found her passion for advocating on behalf of buyers and sellers with their M+A goals. She is excited to bring her skills and network to VERTESS where she has the resources needed to expand her footprint in the healthcare industry.